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www.jacc-interventions.org to view.Long-Term Efﬁcacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of
Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial877Sebastian Kufner, Salvatore Cassese, Marco Valeskini, Franz-Josef Neumann,
Stefanie Schulz-Schüpke, Petra Hoppmann, Massimiliano Fusaro, Heribert Schunkert,
Karl-Ludwig Laugwitz, Adnan Kastrati, Robert A. Byrne, for the ISAR-DESIRE 3
InvestigatorsThis study investigated the long-term comparative efﬁcacy and safety of paclitaxel-eluting balloon
(PEB), paclitaxel-eluting stent (PES), or balloon angioplasty (BA) for the treatment of drug-eluting
stent restenosis. The primary efﬁcacy and safety endpoints were target lesion revascularization and
the composite of death or myocardial infarction. A total of 402 patients were randomly assigned to
receive PEB, PES, or BA alone. At 3-year follow-up, the use of PEB as compared with PES has
similar efﬁcacy and safety. PEB remains superior to BA. The sustained efﬁcacy without trade-off in
safety supports the role of PEB as treatment option for drug-eluting stent restenosis.n EDITORIAL COMMENT
Long-Term Results of Drug-Coated Balloons for Drug-Eluting In-Stent Restenosis:
Gaining Perspective885Fernando Alfonso, Javier Cuesta
Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute
Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS
(DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity)
Randomized Trial (TWENTE II)889Hanim Sen, Ming Kai Lam, Marije M. Löwik, Peter W. Danse, Gillian A.J. Jessurun,
K. Gert van Houwelingen, Rutger L. Anthonio, R. Melvyn Tjon Joe Gin,
Raymond W.M. Hautvast, J. (Hans) W. Louwerenburg, Frits H.A.F. de Man,
Martin G. Stoel, Liefke C. van der Heijden, Gerard C.M. Linssen, Maarten J. IJzerman,
Kenneth Tandjung, Carine J.M. Doggen, Clemens von BirgelenThe 2-year analysis of the randomized DUTCH PEERS trial (TWENTE II) ([DUrable Polymer-Based
STent CHallenge of Promus ElemEnt Versus ReSolute Integrity] Randomized Trial [TWENTE II])
compared clinical events and patient-reported chest pain between all-comer patients treated with
novel, highly-ﬂexible zotarolimus-eluting and everolimus-eluting stents (Resolute Integrity vs.
Promus Element). The rates of the primary endpoint target vessel failure (8.6% vs. 7.8%, p ¼
0.55) and its components were low and were similar between stent groups. At 1 and 2 years,
>80% of patients were free from any chest pain (no between-stent difference); >87% were free
from chest pain during normal daily activities. Chest pain at 1-year at mild-to-moderate physical
effort was associated with a higher risk of consecutive target vessel revascularization.
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JUNE 2015 VOLUME 8, NUMBER 7Impact of Strut Width in Periprocedural Myocardial Infarction:
A Propensity-Matched Comparison Between Bioresorbable Scaffolds and
the First-Generation Sirolimus-Eluting Stent900Hiroyoshi Kawamoto, Vasileios F. Panoulas, Katsumasa Sato, Tadashi Miyazaki,
Toru Naganuma, Alessandro Sticchi, Filippo Figini, Azeem Latib, Alaide Chieffo,
Mauro Carlino, Matteo Montorfano, Antonio ColomboThis study aimed to assess the clinical impact of strut width (evaluated by abluminal strut surface
area) in propensity-matched patients treated with bioresorbable scaffold (BRS) (n ¼ 147) versus
sirolimus-eluting stent (SES) (n ¼ 352). Major adverse cardiac events were not signiﬁcantly
different between groups (1-year major adverse cardiac events: BRS: 15.7% vs. SES: 11.4%, p ¼
0.61). The incidence of periprocedural myocardial infarction was signiﬁcantly higher in the BRS
group (BRS: 13.1% vs. SES: 7.5%, p ¼ 0.05). Multivariable analyses revealed treatment for left
anterior descending artery and abluminal strut surface area to be independent predictors of
periprocedural myocardial infarction.n EDITORIAL COMMENT
Snowshoe Versus Ice Skate for Scaffolding of Disrupted Vessel Wall 910
Patrick W. Serruys, Pannipa Suwannasom, Shimpei Nakatani, Yoshinobu Onuma
The 24-Month Prognosis of Patients With Positive or Intermediate Results in the
Intracoronary Ergonovine Provocation Test914Dong IL Shin, Sang Hong Baek, Sung Ho Her, Seung Hwan Han, Youngkeun Ahn,
Keun-Ho Park, Dong-Soo Kim, Tae-Hyun Yang, Dong-Ju Choi, Jung-Won Suh,
Hyuck Moon Kwon, Byoung Kwon Lee, Hyeon-Cheol Gwon, Seung-Woon Rha,
Sang-Ho JoA total of 2,129 patients who underwent the intracoronary ergonovine provocation for vasospastic
angina (VSA) were classiﬁed into positive (n ¼ 454), intermediate (n ¼ 982), and negative
(n ¼ 693) groups to determine clinical characteristics and 24-month incidences of cardiac death,
new-onset arrhythmia, and acute coronary syndrome. The intermediate group demonstrated
similar clinical characteristics to the negative group and had lower incidences of cardiac death and
repeated angina than the positive group. In the positive group, frequent angina, smoking, and
multivessel spasm were independent predictors for adverse events. The results could suggest the
importance of intensive clinical attention for VSA patients with high risk predictors.n EDITORIAL COMMENT
Provoking Coronary Vasospasm for Diagnosis of Variant Angina:
Outdated Trick of the Trade or a Resurgent Diagnostic Modality?924Ibhar Al Mheid, Salim Hayek, Arshed A. QuyyumiCONTINUED ON PAGE A-24
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JUNE 2015 VOLUME 8, NUMBER 7Plaque Characterization to Inform the Prediction and Prevention of Periprocedural
Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial
(Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)927Gregg W. Stone, Akiko Maehara, James E. Muller, David G. Rizik, Kendrick A. Shunk,
Ori Ben-Yehuda, Philippe Genereux, Ovidiu Dressler, Rupa Parvataneni, Sean Madden,
Priti Shah, Emmanouil S. Brilakis, Annapoorna S. Kini, for the CANARY InvestigatorsNear-infrared spectroscopy was performed in 85 native coronary artery lesions before stent
implantation. Identiﬁcation of lipid-rich plaque as assessed by the maximal lipid core burden index
over any 4-mm length was positively correlated with periprocedural myocardial infarction,
presumably due to distal embolization. However, in patients with lipid-rich plaques with a maximal
lipid core burden index over any 4-mm length $600, randomized use of a distal protection ﬁlter
did not prevent periprocedural myocardial infarction.
SEE ADDITIONAL CONTENT ONLINEMultimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction
During Percutaneous Coronary Intervention937Annapoorna S. Kini, Sadako Motoyama, Yuliya Vengrenyuk, Jonathan E. Feig,
Jacobo Pena, Usman Baber, Arjun M. Bhat, Pedro Moreno, Jason C. Kovacic,
Jagat Narula, Samin K. SharmaMyocardial damage after percutaneous coronary intervention deﬁned as cardiac troponin elevation
has been reported as a procedural complication. Although several intravascular imaging modalities
have been used to predict periprocedural myocardial infarction (MI), it is unclear which of the
imaging tools would best allow prediction of this complication. In this study, we sought to
simultaneously compare the intravascular ultrasound, optical coherence tomography, and near
infrared spectroscopy imaging-based metrics for the risk of periprocedural MI in patients with
stable ischemic heart disease. Optical coherence tomography–based ﬁbrous cap thickness is the
most important predictor of periprocedural MI.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Can Multimodal Invasive Imaging Be Used to Predict Periprocedural
Myocardial Infarctions?946Marc D. Feldman, Jennifer E. PhippsCONTINUED ON PAGE A-25
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JUNE 2015 VOLUME 8, NUMBER 7Single String Technique for Coronary Bifurcation Stenting:
Detailed Technical Evaluation and Feasibility Analysis949Gabor G. Toth, Stylianos Pyxaras, Peter Mortier, Frederic De Vroey, Giuseppe Di Gioia,
Julien Adjedj, Mariano Pellicano, Angela Ferrara, Thomas De Schryver,
Luc Van Hoorebeke, Benedict Verhegghe, Emanuele Barbato, Bernard De Bruyne,
Matthieu De Beule, William WijnsThis study evaluates a novel double-stent bifurcation stenting technique. The single string technique
was tested in vitro (n ¼ 20) and in humans (n ¼ 11). An in vitro favorable outcome was achieved with a
high rate of fully malapposed struts (83.0  9.2%) and low residual area obstruction (6.4  5.6% in
the main branch [MB] and 25.0  16.9% in the side branch [SB]). In humans, the angiographic results
were excellent in the MB and SB and with residual area stenosis of 27  8% and 29  10% in the MB
and in the SB, respectively. During follow-up (6  4 months), no adverse event occurred. The single
string technique for complex bifurcation dilation with 2 stents was shown to be feasible, with
favorable technical and clinical results.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
The Relentless Attempt to Perfect the 2-Stent Technique 960
Antonio Colombo, Neil RupareliaSTRUCTURAL Comparison of Self-Expanding and Mechanically Expanded
Transcatheter Aortic Valve Prostheses962Robert P. Gooley, Andrew H. Talman, James D. Cameron, Siobhan M. Lockwood,
Ian T. MeredithAn increasing number of new-generation transcatheter aortic valve replacement devices are entering
clinical trials and practice with reported safety and efﬁcacy beneﬁts. However, there are very
limited data comparing these devices with current prostheses. The authors present a core
laboratory–adjudicated comparison of a self-expanding device and new mechanically expanded
device.CONTINUED ON PAGE A-26
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JUNE 2015 VOLUME 8, NUMBER 7PERIPHERAL Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a
Blood Pressure– and Heart Rate–Independent Manner972Stephan H. Schirmer, Marwa M.Y.A. Sayed, Jan-Christian Reil, Daniel Lavall,
Christian Ukena, Dominik Linz, Felix Mahfoud, Michael BöhmBecause renal sympathetic denervation (RDN) can affect left ventricular geometry and function next
to a reduction in blood pressure (BP) and heart rate (HR) in certain patients with hypertension, we
aimed to evaluate its effects on left atrial (LA) size and function. Six months after RDN, LA volume
index was reduced by RDN. LA size decrease was independent of the change in BP or HR.
Occurrence of premature atrial contractions on Holter electrocardiogram was reduced. These data
suggest a direct, BP-independent effect of RDN on cardiac remodeling and occurrence of
premature atrial contractions.n EDITORIAL COMMENT
Renal Sympathetic Denervation: Looking Beyond Hypertension 981
Joost Daemen
6-Month Outcomes in Patients With Implantable Cardioverter-Deﬁbrillators Undergoing
Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias984Luciana V. Armaganijan, Rodolfo Staico, Dalmo A.R. Moreira, Renato D. Lopes,
Paulo T.J. Medeiros, Ricardo Habib, Jônatas Melo Neto, Marcelo Katz,
Dikran Armaganijan, Amanda G.M.R. Sousa, Felix Mahfoud, Alexandre AbizaidSympathetic hyperactivity plays a critical role in the development, maintenance, and aggravation of
ventricular arrhythmias (VAs). This study assessed 6-month outcomes in 10 patients undergoing renal
sympathetic denervation (RSD) for refractory VAs. The median number of ventricular tachycardia or
ventricular ﬁbrillation episodes/antitachycardia pacing/shocks 6 months before RSD was 28.5/20.5/
8.0, respectively, and reduced to 1/0/0 and 0/0/0 at 1 and 6 months, respectively. No major
procedure-related complications occurred. In patients with implantable cardiac deﬁbrillators and
refractory VA, RSD reduced arrhythmic burden. Randomized controlled trials investigating RSD for
treatment of refractory VAs are needed.n EDITORIAL COMMENT
Renal Sympathetic Denervation for the Treatment of Ventricular Arrhythmias:
A Lesson in Not Throwing Out the Baby With the Bathwater?991Vivek Y. Reddy, Marc A. MillerCONTINUED ON PAGE A-27
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JUNE 2015 VOLUME 8, NUMBER 7IMAGES IN
INTERVENTIONTranscatheter Mitral Valve Implantation With the FORTIS Device:
Insights Into the Evaluation of Device Success994Omar Abdul-Jawad Altisent, Eric Dumont, François Dagenais, Mario Sénéchal,
Mathieu Bernier, Kim O’Connor, Jean-Michel Paradis, Sylvie Bilodeau,
Sergio Pasian, Josep Rodés-Cabau
A Rare Case of Spontaneous Dissection in a Left Internal Mammary Artery Bypass
Graft in Acute Coronary Syndrome996Kohei Koyama, Kihei Yoneyama, Maya Tsukahara, Shingo Kuwata, Takanobu Mitarai,
Ryo Kamijima, Yuki Ishibashi, Yasuhiro Tanabe, Ken Kongoji, Tomoo Harada,
Yoshihiro J. Akashi
Percutaneous Closure of a Residual Left Atrial Appendage Leak After Lariat Procedure 998
Krishan Soni, Manoj Kesarwani, Nitish Badhwar, Vaikom S. Mahadevan
n ONLINE FEATURE Percutaneous Ventricular Septal Defect Closure After Sapien 3
Transcatheter Aortic Valve Replacemente109Sharayne D. Mark, Vikram Prasanna, Victor A. Ferrari, Howard C. Herrmann
n ONLINE FEATURE Restenosis After Drug-Eluting Stent Implantation in a Patient
With Polycythemia Vera: Optical Coherence Tomography and Pathological Findingse111Akiko Fujino, Hiroyuki Hao, Noriko Kajimoto, Rika Kawakami, Takahiro Imanaka,
Kenichi Fujii, Takashi Abe, Masaharu Ishihara, Seiichi Hirota
n ONLINE FEATURE Internal Mammary Artery Atherosclerosis:
Use of Optical Coherence Tomography to Characterize Lesions and Guide Interventione113Fathi I. Ali
n ONLINE FEATURE First-in-Man Percutaneous Transseptal Closure of
Paravalvular Regurgitation After Percutaneous Valve-in-Ring Implantatione115Ignacio Cruz-Gonzalez, Javier Rodríguez-Collado, Antonio Arribas-Jimenez,
Manuel Barreiro-Perez, Juan Carlos Rama-Merchan, Pedro L. Sanchez
n ONLINE FEATURE Continuous Left Atrial Pressure Monitoring During MitraClip:
Assessing the Immediate Hemodynamic Responsee117Mackram F. Eleid, Saurabh Sanon, Guy S. Reeder, Rakesh M. Suri, Charanjit S. Rihal
n ONLINE FEATURE Aortic Valve Cusps Decalciﬁcation Complicated by an
Embolic Myocardial Infarction Treated by Transradial Intracoronary Embolectomye121Massimo Medda, Francesco Casilli, El Mehdi Ghommidh, Marta Bande, Luigi Inglese
n ONLINE FEATURE THESE ARTICLES DO NOT APPEAR IN THE PRINTED ISSUE.
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